Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

ASX Announcement: Penthrox approved in another 22 European countries

Dec 11, 2017Cathy WilsonNews

12 December 2017

ASX Announcement

Penthrox approved in another 22 European countries

Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for use in an additional 22 European countries today, further underwriting the confidence that global health authorities have in our dossier.

The Medicine and Healthcare products Regulatory Agency (?MHRA?) issued the Final Assessment Report with the support of all European country authorities noting the Decentralised Procedure (DCP) has been successfully completed.? All countries have had the opportunity to review the dossier and in principal agree on the benefits of Penthrox as a widely used analgesic throughout Europe.

 

For the full ASX Announcement, please refer to the following link: ASX Announcement -?ASX Announcement_Penthrox approved in another 22 European countries_121217

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • MVP Completes $25m Placement

    14 December 2020 ASX ANNO...

  • EU Transition and Trading Update

    3 December 2020 ASX ANNOU...

  • MVP Board Re-organisation

    3 December 2020 ASX ANNOU...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me


Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.